Doctors Note Logo

Published on: 9/22/2026

Is there a Farxiga generic available, and is it the same drug?

Farxiga's active ingredient is dapagliflozin, and generic versions have received FDA approval, though U.S. availability has been limited by patent protections and exclusivity timelines that only recently began to expire. An FDA-approved generic must contain the same active ingredient at the same strength and be bioequivalent, meaning it works the same way in the body, but inactive ingredients, appearance, and pricing can differ. Coverage, pharmacy stock, and whether a generic or an authorized generic is offered vary widely, so what you pay may not change as much as expected. There are several important details to consider before switching, including dosing, formulation, and why dapagliflozin was prescribed for you, all explained below.

If you are weighing a switch or noticing new symptoms while managing diabetes, heart failure, or kidney disease, it helps to sort out what needs attention now versus what can wait for your next appointment. A free, instant, online symptom check can help you organize your symptoms, understand possible causes, and plan clear next steps before you talk with a pharmacist or clinician.

Last reviewed for medical accuracy: 09/22/2026

answer background

Explanation

Is There a Farxiga Generic Available, and Is It the Same Drug?

Farxiga (generic name: dapagliflozin) is a prescription medication used to help manage type 2 diabetes and, more recently, certain heart and kidney conditions. Like many brand‐name drugs, Farxiga faced the eventual introduction of a generic version. Below, we’ll explain what a Farxiga generic is, how it compares to the brand‐name medicine, and what you should know before considering a switch.


1. What Is Farxiga?

Farxiga belongs to a class of drugs called SGLT2 inhibitors. It works by helping your kidneys remove excess glucose (sugar) from the body through urine. Originally approved by the U.S. Food and Drug Administration (FDA) in 2014 for type 2 diabetes, Farxiga’s indications have since expanded to include:

  • Reducing the risk of hospitalization for heart failure
  • Slowing the progression of chronic kidney disease

Key points about Farxiga:

  • Active ingredient: dapagliflozin
  • Usual doses: 5 mg or 10 mg once daily
  • Taken by mouth, with or without food

2. Farxiga Generic: Availability and Approval

Yes, there is a generic version of Farxiga. In March 2020, the FDA approved the first generic dapagliflozin tablets. Since then, multiple manufacturers have launched their own dapagliflozin products.

Why Generics Exist

  • Patent expiration: Brand‐name drugs are protected by patents for a set number of years. Once patents expire, other companies can produce generics.
  • Lower cost: Generic drugs typically cost 20–80% less than their brand‐name counterparts.
  • FDA standards: Generics must meet strict FDA requirements for quality, safety and effectiveness.

3. Is the Generic the “Same” Drug?

Yes. By law and by design, a Farxiga generic (dapagliflozin) is bioequivalent to the brand‐name Farxiga. This means:

  • Same active ingredient: Dapagliflozin in the same dose strengths (5 mg, 10 mg).
  • Same mechanism of action: Works identically in the body to reduce blood sugar and support heart/kidney health.
  • Same safety and efficacy: Clinical studies and FDA testing ensure generics perform the same way as the original.

What may differ between brand and generic:

  • Inactive ingredients (binders, fillers, dyes)
  • Tablet shape, size or color
  • Packaging and price

These differences do not affect how the drug works.


4. Benefits of Choosing a Farxiga Generic

  1. Cost savings

    • Generics are often significantly cheaper than brand‐name Farxiga.
    • Lower copays or cash‐pay prices can improve access and adherence.
  2. Wider insurance coverage

    • Insurance plans commonly list generics on preferred tiers.
    • Lower out‐of‐pocket costs may apply.
  3. Proven quality

    • FDA approval requires generics to meet the same high standards as brand drugs.

5. Potential Concerns and Considerations

While generics are safe and effective, you may notice small differences or have questions:

  • Appearance: The tablet color or shape may change if you switch manufacturers.
  • Allergies: Rarely, some people react to an inactive ingredient (dye or filler). If this happens, let your pharmacist know.
  • Insurance formulary: Some plans may require you to try a generic first or ask for prior authorization for the brand.

Always check with your pharmacist or doctor before switching, especially if you have a history of sensitivity to medication components.


6. Common Side Effects of Dapagliflozin

Whether you take brand‐name Farxiga or a generic, the side‐effect profile is the same. The most common side effects include:

  • Urinary tract infections (UTIs)
  • Genital yeast infections
  • Increased urination
  • Mild dehydration

Less common but serious risks (contact a doctor immediately if they occur):

  • Signs of low blood pressure (dizziness, lightheadedness)
  • Ketoacidosis (nausea, vomiting, stomach pain, fatigue, difficulty breathing)
  • Serious urinary tract infections or kidney infections

7. Tips for Safe Use

  • Take dapagliflozin once daily, at the same time each day.
  • Stay hydrated—drink enough water unless your doctor advises otherwise.
  • Monitor blood sugar regularly.
  • Report any unusual symptoms (severe thirst, rapid heart rate, confusion) to your healthcare provider.

Consider trying a free, online symptom check, using the doctor approved Ubie Symptom Checker before your next appointment to track how you’re feeling and prepare questions for your doctor.


8. How to Talk to Your Doctor or Pharmacist

If you’re interested in switching to a generic dapagliflozin, here are steps to take:

  1. Review your current medication
    • Note your dose, frequency and any side effects.
  2. Ask about a generic substitution
    • Your doctor can write “dispense as written” to keep the brand, or allow the generic.
  3. Check insurance coverage
    • Verify copays or prior authorization requirements for both brand and generic.
  4. Follow up
    • After switching, monitor your blood sugar and any side effects.

9. Bottom Line

  • A Farxiga generic (dapagliflozin) is widely available and FDA-approved.
  • Generics are the “same” drug in terms of active ingredient, safety and effectiveness.
  • Choosing a generic often means significant savings with no compromise on quality.
  • Always discuss any change with your healthcare provider to ensure it’s right for you.

If you ever experience serious symptoms—severe abdominal pain, trouble breathing, or symptoms of ketoacidosis—seek medical attention right away. For any ongoing concerns or to manage symptoms, speak to a doctor about what’s best for your health.

(References)

  • * LaCreta F, Griffen SC, Liu X, Smith C, Hines C, Volk K, Tejwani R, Boulton DW. Bioequivalence and food effect of heat-stressed and non-heat-stressed dapagliflozin 2.5- and 10-mg tablets. Int J Pharm. 2016 Sep 10;511(1):288-295. doi: 10.1016/j.ijpharm.2016.07.017. Epub 2016 Jul 12. PMID: 27418571.

  • * Cho HJ, Woo MR, Cho JH, Kim Y Il, Choi HG. Novel dapagliflozin di-L-proline cocrystal-loaded tablet: preparation, physicochemical characterization, and pharmacokinetics in beagle dogs and mini-pigs. Pharm Dev Technol. 2022 Mar;27(3):331-340. doi: 10.1080/10837450.2022.2052320. Epub 2022 Mar 25. PMID: 35264063.

  • * Fatima Z, Atal S, Joshi R, Sadasivam B. Implications and Economic Impact of Applying International Guidelines and Recommendations to the Management of High-Risk Group of Type 2 Diabetes Mellitus Patients in India. Cureus. 2022 Feb;14(2):e22141. doi: 10.7759/cureus.22141. Epub 2022 Feb 11. PMID: 35308676; PMCID: PMC8920807.

  • * Banerjee M, Pal R, Nair K, Mukhopadhyay S. SGLT2 inhibitors and cardiovascular outcomes in heart failure with mildly reduced and preserved ejection fraction: A systematic review and meta-analysis. Indian Heart J. 2023 Mar-Apr;75(2):122-127. doi: 10.1016/j.ihj.2023.03.003. Epub 2023 Mar 11. PMID: 36914068; PMCID: PMC10123444.

  • * Kang SJ, Kim JE. Development of Clinically Optimized Sitagliptin and Dapagliflozin Complex Tablets: Pre-Formulation, Formulation, and Human Bioequivalence Studies. Pharmaceutics. 2023 Apr 14;15(4). doi: 10.3390/pharmaceutics15041246. Epub 2023 Apr 14. PMID: 37111730; PMCID: PMC10141516.

  • * Yang M, Kondo T, Talebi A, Jhund PS, Docherty KF, Claggett BL, Vaduganathan M, Bachus E, Hernandez AF, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Kosiborod MN, Desai AS, Køber L, Ponikowski P, Sabatine MS, Solomon SD, McMurray JJV. Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction. Eur J Heart Fail. 2024 Jul;26(7):1524-1538. doi: 10.1002/ejhf.3263. Epub 2024 May 3. PMID: 38700986.

  • * Yang M, Kondo T, Talebi A, Jhund PS, Docherty KF, Claggett BL, Vaduganathan M, Bachus E, Hernandez AF, Lam CSP, Martinez FA, de Boer RA, Kosiborod MN, Desai AS, Køber L, Ponikowski P, Sabatine MS, Solomon SD, McMurray JJV. EuroQol 5-Dimension Questionnaire in Heart Failure With Reduced, Mildly Reduced, and Preserved Ejection Fraction: A Patient-Level Analysis of DAPA-HF and DELIVER. JACC Heart Fail. 2025 Feb;13(2):277-292. doi: 10.1016/j.jchf.2024.10.020. PMID: 39909641.

  • * Du P, Chen X, Xu Y, Zhou Y, Gao H. Drug-Associated Ketoacidosis: A Comprehensive Disproportionality Analysis Based on the FAERS Database. Diabetes Obes Metab. 2026 Jul;28(7):5893-5906. doi: 10.1111/dom.70790. Epub 2026 Apr 20. PMID: 42010884.

  • * Anderer S. FDA Approves Generic Dapagliflozin. JAMA. 2026 May 19;335(19):1655. doi: 10.1001/jama.2026.2120. PMID: 42030058.

  • * Prasath JH, Garg U, Kurapati K, Baro Agarwal A, Singhal P, Anthuvan T, Gadia S, Gupta A, B SS. Bioequivalence of Fixed-Dose Dapagliflozin-Pioglitazone in Healthy Indian Adults: Results From the Randomized Crossover PRO-4 Study. Cureus. 2026 Jul;18(7):e111872. doi: 10.7759/cureus.111872. Epub 2026 Jul 1. PMID: 42540286; PMCID: PMC13425340.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.